Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,751 public trials 635 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Targeted Microbiome Transplant in Atopic Dermatitis

NCT03151148

Conditions
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • University of California - San Diego San Diego, California, United States
  • National Jewish Health General Clinical Research Center Denver, Colorado, United States
View Trial Details
Completed

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

NCT01157117

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +3 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Oral Immunotherapy for Wheat Allergy

NCT01980992

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +3 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)

NCT03345914

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Regeneron Research Site Birmingham, Alabama, United States
  • Regeneron Research Site Gilbert, Arizona, United States
  • Regeneron Research Site Bakersfield, California, United States
  • Regeneron Research Site Long Beach, California, United States
View all 61 locations
View Trial Details
Completed

Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma

NCT03358147

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Dothan, Alabama, United States
  • Research Site Guntersville, Alabama, United States
View all 232 locations
View Trial Details

Related conditions